Pancreatic Cancer Research

ResearcherChinese Academy of SciencesNo recent work listed

Xing‐Jie Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4793-1705; OpenAlex author ID A5055629026. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy. Co-author DOI 10.1021/acs.nanolett.2c03663↗
  2. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer. Last author DOI 10.1002/exp.20210003↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Na Yu · 1 shared paper, 2022 · strength 0.16
  2. Xingwei Li · 1 shared paper, 2022 · strength 0.16
  3. Shutao Guo · 1 shared paper, 2022 · strength 0.16
  4. Céline Loncle · 1 shared paper, 2021 · strength 0.11
  5. Odile Gayet · 1 shared paper, 2021 · strength 0.11
  6. Juan Liu · 1 shared paper, 2021 · strength 0.11
  7. Ling Peng · 1 shared paper, 2021 · strength 0.11
  8. Juan Iovanna · 1 shared paper, 2021 · strength 0.11
  9. Nelson Dusetti · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.